Influence of recent advances in medical management on clinical outcomes of cirrhosis

Jayant A. Talwalkar, Patrick Sequeira Kamath

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Cirrhosis and its disease-related complications are the 12th leading cause of mortality among US adults and are the 5th leading cause of death for individuals aged 45 to 54 years. Hospitalisation costs for disease-related complications are estimated at $18,000 per episode of care, and 10% of admitted patients die. Despite these ominous findings, the survival rate of patients with cirrhosis has improved during the past 2 decades. This observation coincides with the conducting and reporting of high-quality randomized controlled trials and observational stydies. Therefore, the improved prognosis in cirrhosis may be related to the effective translation of research findings to clinical practice for this patient population. Although explicit data to support this claim are not available, this article reviews the reported trends in clinical outcomes for patients with cirrhosis and the existence of evidence-based medical information that is available to care for these chronically ill patients.

Original languageEnglish (US)
Pages (from-to)1501-1508
Number of pages8
JournalMayo Clinic Proceedings
Volume80
Issue number11
StatePublished - 2005

Fingerprint

Fibrosis
Episode of Care
Cost of Illness
Cause of Death
Hospitalization
Chronic Disease
Survival Rate
Randomized Controlled Trials
Mortality
Research
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Influence of recent advances in medical management on clinical outcomes of cirrhosis. / Talwalkar, Jayant A.; Kamath, Patrick Sequeira.

In: Mayo Clinic Proceedings, Vol. 80, No. 11, 2005, p. 1501-1508.

Research output: Contribution to journalArticle

@article{5f3afa975f50454aa13710903e593b39,
title = "Influence of recent advances in medical management on clinical outcomes of cirrhosis",
abstract = "Cirrhosis and its disease-related complications are the 12th leading cause of mortality among US adults and are the 5th leading cause of death for individuals aged 45 to 54 years. Hospitalisation costs for disease-related complications are estimated at $18,000 per episode of care, and 10{\%} of admitted patients die. Despite these ominous findings, the survival rate of patients with cirrhosis has improved during the past 2 decades. This observation coincides with the conducting and reporting of high-quality randomized controlled trials and observational stydies. Therefore, the improved prognosis in cirrhosis may be related to the effective translation of research findings to clinical practice for this patient population. Although explicit data to support this claim are not available, this article reviews the reported trends in clinical outcomes for patients with cirrhosis and the existence of evidence-based medical information that is available to care for these chronically ill patients.",
author = "Talwalkar, {Jayant A.} and Kamath, {Patrick Sequeira}",
year = "2005",
language = "English (US)",
volume = "80",
pages = "1501--1508",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "11",

}

TY - JOUR

T1 - Influence of recent advances in medical management on clinical outcomes of cirrhosis

AU - Talwalkar, Jayant A.

AU - Kamath, Patrick Sequeira

PY - 2005

Y1 - 2005

N2 - Cirrhosis and its disease-related complications are the 12th leading cause of mortality among US adults and are the 5th leading cause of death for individuals aged 45 to 54 years. Hospitalisation costs for disease-related complications are estimated at $18,000 per episode of care, and 10% of admitted patients die. Despite these ominous findings, the survival rate of patients with cirrhosis has improved during the past 2 decades. This observation coincides with the conducting and reporting of high-quality randomized controlled trials and observational stydies. Therefore, the improved prognosis in cirrhosis may be related to the effective translation of research findings to clinical practice for this patient population. Although explicit data to support this claim are not available, this article reviews the reported trends in clinical outcomes for patients with cirrhosis and the existence of evidence-based medical information that is available to care for these chronically ill patients.

AB - Cirrhosis and its disease-related complications are the 12th leading cause of mortality among US adults and are the 5th leading cause of death for individuals aged 45 to 54 years. Hospitalisation costs for disease-related complications are estimated at $18,000 per episode of care, and 10% of admitted patients die. Despite these ominous findings, the survival rate of patients with cirrhosis has improved during the past 2 decades. This observation coincides with the conducting and reporting of high-quality randomized controlled trials and observational stydies. Therefore, the improved prognosis in cirrhosis may be related to the effective translation of research findings to clinical practice for this patient population. Although explicit data to support this claim are not available, this article reviews the reported trends in clinical outcomes for patients with cirrhosis and the existence of evidence-based medical information that is available to care for these chronically ill patients.

UR - http://www.scopus.com/inward/record.url?scp=27644539711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644539711&partnerID=8YFLogxK

M3 - Article

C2 - 16295030

AN - SCOPUS:27644539711

VL - 80

SP - 1501

EP - 1508

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 11

ER -